Close Menu

NEW YORK (GenomeWeb) – A molecular test from Becton Dickinson to detect 14 high-risk types of human papilloma virus has received pre-market approval from the US Food and Drug Administration, the company announced today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.